Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 2
1990 7
1991 9
1992 15
1993 8
1994 12
1995 17
1996 10
1997 17
1998 10
1999 13
2000 12
2001 15
2002 3
2003 13
2004 11
2005 18
2006 19
2007 21
2008 15
2009 18
2010 14
2011 15
2012 25
2013 22
2014 22
2015 20
2016 24
2017 26
2018 26
2019 13
2020 17
2021 14
2022 10
2023 15

Text availability

Article attribute

Article type

Publication date

Search Results

485 results

Results by year

Filters applied: . Clear all
Page 1
Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis.
Tamura R. Tamura R. Int J Mol Sci. 2021 May 29;22(11):5850. doi: 10.3390/ijms22115850. Int J Mol Sci. 2021. PMID: 34072574 Free PMC article. Review.
Neurofibromatosis (NF) is a neurocutaneous syndrome characterized by the development of tumors of the central or peripheral nervous system including the brain, spinal cord, organs, skin, and bones. There are three types of NF: NF1 accounting for 96% of all cases, NF2 in 3%
Neurofibromatosis (NF) is a neurocutaneous syndrome characterized by the development of tumors of the central or peripheral nervous s
Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis.
Bachir S, Shah S, Shapiro S, Koehler A, Mahammedi A, Samy RN, Zuccarello M, Schorry E, Sengupta S. Bachir S, et al. Int J Mol Sci. 2021 Jan 12;22(2):690. doi: 10.3390/ijms22020690. Int J Mol Sci. 2021. PMID: 33445724 Free PMC article. Review.
Patients diagnosed with neurofibromatosis type 2 (NF2) are extremely likely to develop meningiomas, in addition to vestibular schwannomas. ...In NF2, patients have mutations in the NF2 gene, specifically with loss of function in a tumor-suppressor protein tha …
Patients diagnosed with neurofibromatosis type 2 (NF2) are extremely likely to develop meningiomas, in addition to vest …
Neurofibromatosis type 2.
Asthagiri AR, Parry DM, Butman JA, Kim HJ, Tsilou ET, Zhuang Z, Lonser RR. Asthagiri AR, et al. Lancet. 2009 Jun 6;373(9679):1974-86. doi: 10.1016/S0140-6736(09)60259-2. Epub 2009 May 22. Lancet. 2009. PMID: 19476995 Free PMC article. Review.
Neurofibromatosis type 2 is an autosomal-dominant multiple neoplasia syndrome that results from mutations in the NF2 tumour suppressor gene located on chromosome 22q. ...We review the molecular pathogenesis, genetics, clinical findings, and management strateg
Neurofibromatosis type 2 is an autosomal-dominant multiple neoplasia syndrome that results from mutations in the NF2 tu
Neurofibromatosis type 2 and related disorders.
Halliday D, Parry A, Evans DG. Halliday D, et al. Curr Opin Oncol. 2019 Nov;31(6):562-567. doi: 10.1097/CCO.0000000000000579. Curr Opin Oncol. 2019. PMID: 31425178 Review.
PURPOSE OF REVIEW: Neurofibromatosis type 2 (NF2) is a schwannoma predisposition syndrome, alongside schwannomatosis related to germline LZTR1 and SMARCB1 pathogenic variants. ...
PURPOSE OF REVIEW: Neurofibromatosis type 2 (NF2) is a schwannoma predisposition syndrome, alongside schwannomatosis re …
Neurofibromatosis type 1.
Cimino PJ, Gutmann DH. Cimino PJ, et al. Handb Clin Neurol. 2018;148:799-811. doi: 10.1016/B978-0-444-64076-5.00051-X. Handb Clin Neurol. 2018. PMID: 29478615 Review.
The neurofibromatoses are a group of three heterogeneous disorders that include neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis. ...
The neurofibromatoses are a group of three heterogeneous disorders that include neurofibromatosis type 1 (NF1), neurofibrom
Neurofibromatosis Type 2.
Ardern-Holmes S, Fisher G, North K. Ardern-Holmes S, et al. J Child Neurol. 2017 Jan;32(1):9-22. doi: 10.1177/0883073816666736. Epub 2016 Sep 29. J Child Neurol. 2017. PMID: 27655473 Review.
Neurofibromatosis type 2 (NF2) is a rare autosomal dominant disorder (incidence 1:33 000-40 000) characterized by formation of central nervous system tumors, due to mutation in the NF2 gene on chromosome 22q12. ...
Neurofibromatosis type 2 (NF2) is a rare autosomal dominant disorder (incidence 1:33 000-40 000) characterized by forma
An update on the CNS manifestations of neurofibromatosis type 2.
Coy S, Rashid R, Stemmer-Rachamimov A, Santagata S. Coy S, et al. Acta Neuropathol. 2020 Apr;139(4):643-665. doi: 10.1007/s00401-019-02029-5. Epub 2019 Jun 4. Acta Neuropathol. 2020. PMID: 31161239 Free PMC article. Review.
Neurofibromatosis type II (NF2) is a tumor predisposition syndrome characterized by the development of distinctive nervous system lesions. ...
Neurofibromatosis type II (NF2) is a tumor predisposition syndrome characterized by the development of distinctive nervous sys
Neurofibromatosis.
Korf BR. Korf BR. Handb Clin Neurol. 2013;111:333-40. doi: 10.1016/B978-0-444-52891-9.00039-7. Handb Clin Neurol. 2013. PMID: 23622184 Review.
The genes that underlie each of the disorders are known: NF1 for neurofibromatosis type 1, NF2 for neurofibromatosis type 2, and INI1/SMARCB1 for schwannomatosis. ...
The genes that underlie each of the disorders are known: NF1 for neurofibromatosis type 1, NF2 for neurofibromatosis
Diagnostic Pathology of Tumors of Peripheral Nerve.
Belakhoua SM, Rodriguez FJ. Belakhoua SM, et al. Neurosurgery. 2021 Feb 16;88(3):443-456. doi: 10.1093/neuros/nyab021. Neurosurgery. 2021. PMID: 33588442 Free PMC article. Review.
We also discuss the diagnostic relevance of these neoplasms to specific genetic and familial syndromes of nerve, including neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis. In addition, we discuss updates in our understanding of the molecular alt …
We also discuss the diagnostic relevance of these neoplasms to specific genetic and familial syndromes of nerve, including neurofibromato
Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis.
Ahlawat S, Blakeley JO, Langmead S, Belzberg AJ, Fayad LM. Ahlawat S, et al. Skeletal Radiol. 2020 Feb;49(2):199-219. doi: 10.1007/s00256-019-03290-1. Epub 2019 Aug 8. Skeletal Radiol. 2020. PMID: 31396668 Review.
Neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis (SWN) are three clinically distinct tumor predisposition syndromes with a shared tendency to develop peripheral and central nervous system neoplasms. ...
Neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis (SWN) are three clini
485 results